EED related overgrowth: First report of multiple members in a single family

Am J Med Genet A. 2024 Feb;194(2):374-382. doi: 10.1002/ajmg.a.63438. Epub 2023 Oct 16.

Abstract

EED is a core component of polycomb repressive complex 2 (PRC2) with EZH2 and SUZ12. PRC2 has H3K27 methyltransferase activity (HMTase) that catalyzes the addition of up to three methyl groups on histone 3 at lysine residue 27 (H3K27). Germline heterozygous variants in EED, SUZ12, and EZH2 have been identified in patients with overgrowth and multiple dysmorphic features. The clinical manifestations of these syndromes significantly overlap: generalized overgrowth, intellectual disability, and scoliosis. To date, 11 unrelated patients have been published with missense variants in EED at highly conserved amino acids. We report three affected members in a family with a previously reported missense variant. All three affected members manifested very similarly, and this represents a homogenous clinical phenotype associated with EED related intellectual disability and overgrowth. This disorder is appropriately called Cohen-Gibson syndrome.

Keywords: Cohen-Gibson syndrome (COGIS); EED; global developmental delay; histone; intellectual disability; overgrowth.

Publication types

  • Case Reports

MeSH terms

  • Enhancer of Zeste Homolog 2 Protein* / genetics
  • Histones / genetics
  • Humans
  • Intellectual Disability* / diagnosis
  • Intellectual Disability* / genetics
  • Mutation, Missense / genetics
  • Polycomb Repressive Complex 2 / genetics

Substances

  • Enhancer of Zeste Homolog 2 Protein
  • Polycomb Repressive Complex 2
  • Histones
  • EED protein, human